Call Us: (877) 565 3287


Frequently Asked Questions

Patients with blood cancers such as leukemia and lymphoma, sickle cell and other life-threatening diseases depend on a bone marrow, stem cell or cord blood transplant (HSCT) for the chance at living a healthy life once again. The following questions are frequently asked by patients, families and friends trying to find a life-saving cure to their diseases.

None of the information presented in these FAQs is meant to be, nor should be taken as, medical advice. Kashi Clinical Laboratories strongly encourages the reader to seek the advice of a qualified medical doctor before using any of the information or products and services available on the website.

Hematopoietic stem cell transplantation (HSCT) entails the use of multipotent Hematopoietic Stem Cells, typically from bone marrow, peripheral blood, or umbilical cord blood. HSCT is often a treatment of choice for patients with multiple myeloma, leukemia and other cancers of the blood or bone marrow. In these procedures, patients first undergo radiation or Chemotherapy to wipe out their immune system. Next, they receive HSCT cells from a matching donor identified through lab results or Registries with data bases of volunteer donors.

Did we answer your questions?

If you didn't find the answer you were looking for here, please check our other Frequently Asked Questions categories below.